Biomarkers 2012

Date
Start Date: 
Wednesday, September 26, 2012
End Date: 
Wednesday, September 26, 2012

London:


Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. 



Book your seats online here http://www.virtueinsight.com/pharma/Biomarkers-2012/ 

Key Themes Discussed at this Conference: 
• Biomarker Discovery & Validation - Government policies & strategies 
• Companion Diagnostics & Personalized Medicine 
• Safety & Biomarkers in Clinical Development 
• Enabling Technologies to Maximise Biomarker Identification 
• Discuss how biomarkers can accelerate your clinical development 
• Design strategies for success in early phase trials 
• Showing clinical utility of biomarkers to improve diagnosis & make informed decision making 
• See how improvements in technologies are leading to better efficiency of biomarkers 
• Analyze biomarkers and their role in drug development 
• Development and Application of Clinical Safety Biomarkers with a focus on imaging biomarkers
• Assess preclinical safety considerations 
• Identifying current developments in Biomarkers & ways to overcome threats 
• Discovering successful business models - Opportunities & Challenges 
• Emerging stratified medicine via successful partnerships 
• Network in our combined exhibition and catering area 
• Evening networking reception for all attendees 


Key Speakers: 
• Mark Broenstrup, Director Biomarkers & Diagnostics, Sanofi-Aventis 
• Joachim Reischl, Head Global Biomarker Strategy and Development, Bayer Pharma 
• Jochen Theis, Owner & Principal Consultant, InHeCon (Germany) – Former Global Head, Biomarkers, F. Hoffmann-La Roche 
• David W. Moskowitz, Chairman, CEO & CMO, GenoMed (USA) 
• John Lambert, Vice President and Chief Medical Officer Clinical Pharmacology, Parexel 
• Sylvie Le Glédic, Director, Voisin Consulting Life Sciences 
• Mohamed Oubihi, EU Regulatory Intelligence Lead, International Regulatory Affairs, Biogen Idec 
• Malcolm I Mitchell, Senior Medical Fellow, Clinical Pharmacology, Eli Lilly 
• Austin Tanney, Scientific Liaison Manager, Almac Diagnostics 
• Eugenii (Ilan) A. Rabiner, Head, Imaging Applications & CMO, Imanova 
• Lincoln Tsang, Partner, Arnold & Porter LLP 
• Maria Hernandez Fuentes, Senior Lecturer in Translational Research, L.O.R.D. lab. MRC Centre for Transplantation, King's College London 

Plus Many More... 

ArticleTools

Featured Reports

Understanding and Capitalizing Upon Telecom APIs for Communications Enabled Applications
Big Data and Analytics software and applications will play a crucial role in making IoT a success. The data generated through sensors embedded in various things/objects will generate massive amounts of unstructured (big) data on real-time basis that holds the promise for intelligence and insights for dramatically improved decision processes.

Content Delivery Networks (CDN) 2015
Content Delivery Networks (CDN) represent large distributed system of servers deployed in multiple data centers across the Internet. CDNs provide solutions for efficiently and effectively managing content of all types. Solutions include core services such as aggregation, management, and distribution of content as well as a variety of value-added functionality.

Technologies Impacting and Impacted by Operational Support Systems (OSS)
There are significant changes underway in the CSP industry that are causing fundamental re-evaluations of business models, technology stacks and service offerings. This research assesses a range of relatively nascent technologies that have the potential to change the dynamic of OSS, whether via the networks they manage, or as building blocks on which to build better OSS tools.

Market Opportunity: Big Data in the Internet of Things
Big Data and Analytics software and applications will play a crucial role in making IoT a success. The data generated through sensors embedded in various things/objects will generate massive amounts of unstructured (big) data on real-time basis that holds the promise for intelligence and insights for dramatically improved decision processes.

Concise, Practical Market Reports on Big Data, IoT, CDN & More!
Access the exclusive new series of market research reports brought to you through the partnership of Mind Commerce research and TelecomEngine.com.
Browse the latest titles

 

 

Featured Events & Partners

GEN 15
Nov. 16-19, 2015

Omni Hotel, Dallas, Texas

The global gathering of networking professionals enabling the future of agile, assured and orchestrated services powered by CE 2.0, LSO (Lifecycle Service Orchestration), SDN and NFV.

Visit event website...
 

 

Business Wire